Ymmunobio company logo with antibody symbol and text in blue and red on transparent background
Ymmunobio company logo with antibody symbol and text in white on transparent background
Contact

 /   News

Latest developments updates & insights

News

Latest news

Stay informed with the latest company announcements, research milestones & scientific publications from Ymmunobio.

All news

Dr. Peter Schiemann, CEO and Co-Founder of Ymmunobio, featured in Global Business Reports 2024 interview on oncology strategy

Global Business Report interviews Ymmunobio CEO Peter Schiemann

Ymmunobio team selected for Venture Leaders Biotech 2024 group photo representing top Swiss biotech startups

Ymmunobio has been selected for the Venture Leaders Biotech 2024!

Ymmunobio banner with company logo and tagline Cancer Therapies for Tomorrow and Beyond

Successful completion of the seed funding round for Ymmunobio!

Ymmunobio CIMT 2023 poster presenting YB-200 antibody targeting CEACAM1/5 showing complete tumor response in mice

2023 CIMT Annual Meeting Poster Presentation

Scientist presenting research poster at the 20th CIMT Annual Meeting 2023 focused on cancer immunotherapy

Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Dr. Katrin Rupalla, CEO of Ymmunobio, featured in Global Business Reports Life Sciences 2023 interview

Dr. Katrin Rupalla Interviewed by Global Business Reports